4SHEP Cooperative Research Group.Prevention of strokeby antihypertensive drug treatment in older persons with isolated systolic hypertension.Final results of the Systolic Hypertension in the Elderly Program (SHEP)[J].JAMA ,1991,265:3255.
5Hansson L, Dahlof B, Ekbom T, et a1. Key leanings from the STOP-hypertension study:all update on the progress of the ongoing Swedish study of antihypertensive treatment in the elderly[J]. Cardiovasc Drug Ther ,l990,4:1253.
6Gong L.Zhang W .Zhu Y,et a1. Shanghai Trial of Nifedipine in the Elderly(STONE) [J].J Hypertens, l996,4:237.
7Klungel OH,Kaplan RC,Heckbert SR,et a1.Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients[J]. Stroke ,2003,1:420.
8Chalrners J,Beilin L,Maneia G,et al.International Society of Hypertension(ISH):statement on blood pressure and stroke[J].J Hypertens,2003,21:649
9The European Stroke Initiative Executive Committee and EUSI Writing Committe .European Stroke Initiative Recommendations for Stroke Management update 2003[J].Cerebrovasc Dis, 2003,16:3l1
10Adams Jr,Adams I ,et a1.Guidelines for the early management of patients with ischemie stroke:A scientific statement from the Stroke Counci1 of the American Stroke Association[J].Stroke, 2003,34:1056.
6Hurwitz HI, Douglas PS, Middleton JP, et al. Analysis of early hy- pertension and clinical outcome with bevacizumab: results from seven phase Ⅲ studies [ J ]. Oncologist ,2013,18 (3) :273-280.
7Abad-Cardiel M, Alvarez-tdvarez B, Luque-Femandez L, et al. Hypertension caused by primary hyperaldosteronism: increased heart damage and cardiovascular risk [ J ]. Rev Esp Cardiol,2013, 66( 1 ) :47-52.
